Tempus AI (NASDAQ:TEM) Stock Price Down 1.8% – What’s Next?

Tempus AI, Inc. (NASDAQ:TEM) traded down 1.8% on Monday . The stock traded as low as $77.66 and last traded at $79.05. 4,353,281 shares changed hands during mid-day trading, a decline of 65% from the average session volume of 12,584,122 shares. The stock had previously closed at $80.52.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on TEM. Guggenheim boosted their price objective on shares of Tempus AI from $65.00 to $75.00 and gave the company a “buy” rating in a research report on Monday, June 30th. Bank of America boosted their price objective on shares of Tempus AI from $68.00 to $70.00 and gave the company a “neutral” rating in a research report on Wednesday, June 25th. BTIG Research boosted their price objective on shares of Tempus AI from $75.00 to $85.00 and gave the company a “buy” rating in a research report on Wednesday, August 20th. Piper Sandler reissued a “neutral” rating on shares of Tempus AI in a research report on Friday, August 8th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $70.00 price objective on shares of Tempus AI in a research report on Friday, August 8th. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $67.64.

Tempus AI Price Performance

The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. The firm has a market cap of $13.22 billion, a P/E ratio of -64.07 and a beta of 4.98. The firm has a 50-day simple moving average of $63.78 and a 200-day simple moving average of $59.10.

Tempus AI (NASDAQ:TEM) last announced its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.23) by $0.01. The business had revenue of $314.64 million for the quarter, compared to analysts’ expectations of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The business’s revenue for the quarter was up 89.5% on a year-over-year basis. During the same quarter last year, the firm earned ($6.86) EPS. Tempus AI has set its FY 2025 guidance at EPS. As a group, analysts forecast that Tempus AI, Inc. will post -6.15 EPS for the current year.

Insider Activity

In related news, Director Theodore Leonsis sold 205,847 shares of the business’s stock in a transaction that occurred on Wednesday, June 11th. The shares were sold at an average price of $67.66, for a total transaction of $13,927,608.02. Following the completion of the transaction, the director owned 15,511 shares in the company, valued at $1,049,474.26. The trade was a 92.99% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Ryan Fukushima sold 17,460 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $1,303,389.00. Following the transaction, the chief operating officer owned 839,180 shares of the company’s stock, valued at approximately $62,644,787. This trade represents a 2.04% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 776,451 shares of company stock worth $53,022,688 over the last 90 days. 26.27% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of TEM. Vanguard Group Inc. raised its stake in shares of Tempus AI by 6,247.5% during the 1st quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company’s stock worth $289,204,000 after acquiring an additional 5,900,668 shares in the last quarter. ARK Investment Management LLC lifted its stake in shares of Tempus AI by 35.9% during the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company’s stock worth $361,867,000 after buying an additional 1,981,755 shares during the period. Nikko Asset Management Americas Inc. grew its holdings in shares of Tempus AI by 31.5% during the first quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company’s stock valued at $205,401,000 after buying an additional 1,021,460 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. raised its stake in Tempus AI by 31.4% in the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company’s stock worth $205,284,000 after acquiring an additional 1,016,384 shares during the last quarter. Finally, AQR Capital Management LLC purchased a new position in Tempus AI in the 2nd quarter worth $54,020,000. Institutional investors own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.